Saidal Signs Memorandum of Understanding with Swiss Group

The Saidal Group, yesterday, Sunday, signed a Memorandum of Understanding (MoU) with the Swiss group "Bioexpress Therapeutics," in a new step reflecting the two parties' desire to enhance international cooperation in the fields of pharmaceutical industry and biotechnology.

According to a statement from the Saidal Group, the MoU aims to "establish a strategic cooperation framework primarily focused on training and developing competencies in the field of biotechnology, paving the way for a gradual and organized technology transfer process."

This partnership also seeks to create suitable conditions for the local production of biotechnological products, thereby enhancing national capabilities and supporting the path towards achieving health sovereignty.

Through this agreement, the Saidal Group reaffirms its commitment to supporting innovation, developing national expertise, and integrating advanced technologies, in addition to expanding its network of strategic partnerships with leading international players in the pharmaceutical industry and biological treatments sector.